Vandetanib for the treatment of lung cancer.

about

RET fusion gene: translation to personalized lung cancer therapy Identification of reproducible gene expression signatures in lung adenocarcinoma.Anti-EGFR Agents: Current Status, Forecasts and Future Directions.

P2860

Q33711282-CF23E4BD-89FA-4DDE-B73C-E92C4909013A Q35076226-31F8E4C4-6751-4D4D-8887-1D4D879D383D Q38832105-3F03AA5E-BBE7-4757-848F-1EEC179911B9

P2860

Vandetanib for the treatment of lung cancer.

Item

http://www.wikidata.org/entity/Q38016190

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Vandetanib for the treatment of lung cancer.

@en

type

Item

label

Vandetanib for the treatment of lung cancer.

@en

prefLabel

Vandetanib for the treatment of lung cancer.

@en

P1476

Vandetanib for the treatment of lung cancer.

@en

P2093

Caleb T Chu

http://www.w3.org/2001/XMLSchema#string

Edward S Kim

http://www.w3.org/2001/XMLSchema#string

Yvonne H Sada

http://www.w3.org/2001/XMLSchema#string

P2860

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Cancer statistics, 2010

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

RET tyrosine kinase signaling in development and cancer

P304

1211-1221

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.2012.694866

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22667325

http://www.w3.org/2001/XMLSchema#string

P921

vandetanib

Vandetanib for the treatment of lung cancer.

about

P2860

P2860

Vandetanib for the treatment of lung cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921